Indicators

Markets:

News

Latest News about FGEN

Recent news which mentions FGEN

< Previous 1 2 3 4 5 6 Next >

Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021

August 20, 2021

After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat

August 20, 2021

Here's What Recent News From the FDA Means for AstraZeneca

August 20, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

22 Stocks Moving in Friday's Pre-Market Session

August 20, 2021

A Peek Into The Markets: US Stock Futures Down Ahead Of Earnings; Crude Oil Edges Lower

August 20, 2021

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

August 13, 2021

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

August 12, 2021

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

August 11, 2021

FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial

August 11, 2021

10 Biggest Price Target Changes For Tuesday

August 10, 2021

FibroGen, inc (FGEN) Q2 2021 Earnings Call Transcript

August 10, 2021

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

August 08, 2021

10 Health Care Stocks Showing Unusual Options Activity In Today's Session

August 02, 2021

What's Next for FibroGen After an FDA Vote Against Its Anemia Drug?

July 29, 2021

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal

July 28, 2021

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts

July 27, 2021

FibroGen Out-Licenses Recombinant Human Collagen-Based Biosynthetic Cornea

July 19, 2021

50 Biggest Movers From Friday

July 19, 2021

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs

July 18, 2021

Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; Aehr Test Systems Shares Spike Higher

July 16, 2021

Here's Why FibroGen Stock Is Plunging Today

July 16, 2021

FibroGen Analyst Removes Roxadustat Sales From Model After AdCom Snub

July 16, 2021

Market Update: The 10 Most Active Stocks on Friday

July 16, 2021

33 Stocks Moving In Friday's Mid-Day Session

July 16, 2021

GLG Stock: The M&A News Causing Penny Stock TD Holdings to Skyrocket Today

July 16, 2021

Analyzing FibroGen's Unusual Options Activity

July 16, 2021

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.